Galena Biopharma In The News
- Galena Biopharma Doses First Patient in GALE-401 (Anagrelide Controlled Release) Phase 2 Clinical Trial
- Galena Biopharma to Present at the Rodman & Renshaw 16th Annual Global Investment Conference
- Galena Biopharma Appoints Mark W. Schwartz, Ph.D., as President and Chief Executive Officer
- Galena Biopharma Reports Second Quarter 2014 Results
Galena is committed to ensuring eligible patients have access to our products. Learn more at GalenaPatientServices.com.